Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Microbes hijack prostate cancer therapy Androgens such as testosterone and dihydrotestosterone are essential for male reproduction and sexual function. Androgens can also influence the growth of prostate tumor cells, and androgen deprivation therapy (ADT) either by surgical means (castration) or pharmacological approaches (hormone suppression), is the cornerstone of current prostate cancer treatments. Pernigoni et al . found that when the body was deprived of androgens during ADT, the gut microbiome could produce androgens from androgen precursors (see the Perspective by McCulloch and Trinchieri). Gut commensal microbiota in ADT-treated patients or castrated mice produced androgens that were absorbed into the systemic circulation. These microbe-derived androgens appeared to favor the growth of prostate cancer and helped to facilitate development into a castration- or endocrine therapy–resistant state. —PNK
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“polychemotherapy and endocrine therapy (such as androgen deprivation) can modulate the alpha and beta diversities of the microbiota, which have been proposed to affect treatment-related adverse events27,28 as well as drug metabolism and efficacy29,30.”
From Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy (2023) · cites this paper as [29]
In the citing paper
“Nonetheless, we identified that participants with metastatic prostate cancer also cluster in the same cancerassociated clade as those with melanoma. 54”
From Global genetic diversity of human gut microbiome species is related to geographic location and host health (2025) · cites this paper as [54]
In the citing paper
“The original study indicated that some bacteria could produce androgens, such as testosterone, which are associated with adverse cancer outcomes. 54”
From Global genetic diversity of human gut microbiome species is related to geographic location and host health (2025) · cites this paper as [54]
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data
McMurdie, P. J., & Holmes, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061217 · Cited by 21,322
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
Sumner, L. W., Amberg, A., Barrett, D., Beale, M. H., Beger, R., Daykin, C. A., Fan, T. W.-M., Fiehn, O., Goodacre, R., Griffin, J. L., et al. (2007) · Metabolomics · doi:10.1007/s11306-007-0082-2 · Cited by 5,368
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing
Bokulich, N. A., Subramanian, S., Faith, J. J., Gevers, D., Gordon, J. I., Knight, R., Mills, D. A., & Caporaso, J. G. (2013) · Nature Methods · doi:10.1038/nmeth.2276 · Cited by 4,401
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888
Cited by
Items 101–200 of 326
Pan, R., Guo, M., Chen, Y., Lin, G., Tian, P., Wang, L., Zhao, J., Chen, W., & Wang, G. (2024) · Nutrients · doi:10.3390/nu16040483 · Cited by 26
Gut microbiome: a novel preventive and therapeutic target for prostatic disease
Cao, H., Zhang, D., Wang, P., Wang, Y., Shi, C., Wu, H., Du, H., Zhang, W., Gou, Z., Zhou, H., et al. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1431088 · Cited by 26
Gao, D., Shen, Y., Xu, L., Sun, Y., Hu, H., Xu, B., Wang, Z., & Xu, H. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2024.101158 · Cited by 22
Ruszkowski, J., Kachlik, Z., Walaszek, M., Storman, D., Podkowa, K., Garbarczuk, P., Jemioło, P., Łyzińska, W., Nowakowska, K., Grych, K., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06645-6 · Cited by 28
Wu, L., Han, J., Nie, J.-Y., Deng, T., Li, C., Fang, C., Xie, W., Wang, S.-Y., & Zeng, X. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.865191 · Cited by 27
Zhang, Z., Lu, W., Liu, P., Li, M., Ge, X., Yu, B., Wu, Z., Liu, G., Ding, N., Cui, B., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155068 · Cited by 20
Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer
Calì, B., Troiani, M., Bressan, S., Attanasio, G., Merler, S., Moscarda, V., Mosole, S., Ricci, E. D., Guo, C. W., Yuan, W., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.08.018 · Cited by 24
Self-citationZhai, X., Chen, X., Wan, Z., Ge, M., Ding, Y., Gu, J., Hua, J., Guo, D., Tan, M., & Xu, D. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1136835 · Cited by 19
Romano, L., Napolitano, L., Crocetto, F., Sciorio, C., SIO, M. D., Miranda, A., Romano, M., & Priadko, K. (2024) · The Prostate · doi:10.1002/pros.24675 · Cited by 22
Different Roles of Tocopherols and Tocotrienols in Chemoprevention and Treatment of Prostate Cancer
Jiang, Q. (2024) · Advances in Nutrition · doi:10.1016/j.advnut.2024.100240 · Cited by 21
Zhou, Y., Lv, J., Jin, S., Fu, C., Liu, B., Shen, Y., Li, M., Zhang, Y., & Feng, N. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1526051 · Cited by 30
Jayaprakash, M., Kumar, D. V., Chakraborty, G., Chakraborty, A., & Kumar, V. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118559 · Cited by 24
Effect of Radium-223 on the Gut Microbiota of Prostate Cancer Patients: A Pilot Case Series Study
Fernandes, A. R., Oliveira, A. B. F. D., Soares-Guedes, C., Fernandes, R., Soares, R. A., & Barata, P. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44100336 · Cited by 19
Diviccaro, S., Falvo, E., Piazza, R., Cioffi, L., Herian, M., Brivio, P., Calabrese, F., Giatti, S., Caruso, D., & Melcangi, R. C. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109405 · Cited by 22
Fecal Microbiota Transplantation as a Cancer Therapeutic
Stoff, R., Wolf, Y., & Boursi, B. (2023) · The Cancer Journal · doi:10.1097/ppo.0000000000000651 · Cited by 23
The human microbiome links to prostate cancer risk and treatment (Review)
Xia, B., Wang, J., Zhang, D., & Hu, X. (2023) · Oncology Reports · doi:10.3892/or.2023.8560 · Cited by 19
Wang, L. (2023) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-023-00723-w · Cited by 20
Dysbiotic microbes and how to find them: a review of microbiome profiling in prostate cancer
Salachan, P. V., & Sørensen, K. D. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02196-y · Cited by 18
Lin, M., Sun, X. K., & Lv, L. (2023) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2023.04.007 · Cited by 22
Association between vaginal microbiota and the progression of ovarian cancer
Li, C., Feng, Y., Yang, C., Wang, D., Zhang, D., Luo, X., Zhang, H., Huang, H., Zhang, H., Jiang, Y., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28898 · Cited by 20
Kalinen, S., Kallonen, T., Gunell, M., Ettala, O. O., Jambor, I., Knaapila, J., Syvänen, K. T., Taimen, P., POUTANEN, M. H., Aronen, H. J., et al. (2024) · European Urology Open Science · doi:10.1016/j.euros.2024.02.004 · Cited by 22
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy
Chen, C., Han, P., & Qing, Y. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103579 · Cited by 17
The Urogenital System Microbiota: Is It a New Gamechanger in Urogenital Cancers?
Ece, G. T., Aktaş, A., Caner, A., Sağlık, İ., Atik, T. K., Bağcı, Ö. U., Bilman, F. B., Demirbakan, H., Havuz, S. G., Kaya, E., et al. (2025) · Microorganisms · doi:10.3390/microorganisms13020315 · Cited by 17
Tang, L., Yang, X., Zhou, M., Feng, L., Ji, C., Liang, J., Zhang, B., Shen, R., & Wang, L. (2024) · mSystems · doi:10.1128/msystems.00138-24 · Cited by 20
Specific Gut Microbial Environment in Lard Diet-Induced Prostate Cancer Development and Progression
Sato, H., Narita, S., Ishida, M., Takahashi, Y., Huang, M., Kashima, S., Yamamoto, R., Koizumi, A., Nara, T., Numakura, K., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042214 · Cited by 18
Wu, R., Shen, Q., Li, P., & Shang, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073723 · Cited by 17
Christenson, M., Song, C. S., Liu, Y., & Chatterjee, B. (2022) · Cancers · doi:10.3390/cancers14040892 · Cited by 15
Reprogramming prostate cancer through the microbiome
Bautista, J., Maya, W. D. C., Gancino-Guevara, K., & López-Cortés, A. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1690498 · Cited by 19
The role of diet in cancer: the potential of shaping public policy and clinical outcomes in the UK
Britten, O., & Tosi, S. (2024) · Genes & Nutrition · doi:10.1186/s12263-024-00750-9 · Cited by 20
Akkermansia muciniphila Metabolite Inosine Inhibits Castration Resistance in Prostate Cancer
Yu, Y., Li, L., Yang, Q., Xue, J., Wang, B., Xie, M., Shangguan, W., Zhu, Z., & Wu, P. (2024) · Microorganisms · doi:10.3390/microorganisms12081653 · Cited by 18
Zhang, W., Xie, J., Wang, Z., Zhong, Y., Liu, L., Liu, J., Zhang, W., Pi, Y., Tang, F., Liu, Z., et al. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128047 · Cited by 17
Mohamed, A. R., Ochsenkühn, M. A., Haydon, T. D., Abdelrazig, S., Coe, L. S. Y., Mochales-Riano, G., Jo, W. S., Healy, A., Abrego, D., Raina, J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.19.558257 · Cited by 14
Li, J., Li, Y., Zhou, L., Li, C., Liu, J., Liu, D., Fu, Y., Wang, Y., Tang, J. H., Zhou, L., et al. (2024) · Microbiological Research · doi:10.1016/j.micres.2023.127596 · Cited by 17
From pathogenesis to treatment: the impact of bacteria on cancer
Lu, J., & Tong, Q. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1462749 · Cited by 14
The gut microbiota can be a potential regulator and treatment target of bone metastasis
Contino, K. F., Yadav, H., & Shiozawa, Y. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114916 · Cited by 17
Lin, P., Howard, L. E., & Freedland, S. J. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2069853 · Cited by 17
Nutrition and Microbiome Interactions in Human Cancer
Daschner, P. J., Ross, S., Seifried, H. E., Kumar, A., & Flores, R. (2022) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2022.10.004 · Cited by 14
Interaction between the breast tumor microenvironment and gut microbiome
Tang, G., Millar, E. K. A., Graham, P., & Beretov, J. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2514136 · Cited by 15
RANKL and RANK in Cancer Therapy
Onji, M., & Penninger, J. M. (2022) · Physiology · doi:10.1152/physiol.00020.2022 · Cited by 16
Prostate Cancer and the Mevalonate Pathway
Guerrero‐Ochoa, P., Rodríguez-Zapater, S., Anel, A., Esteban, L. M., Camón-Fernández, A., Espílez, R., Gil‐Sanz, M. J., & Borque‐Fernando, Á. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042152 · Cited by 16
Prostate Tissue Microbiome in Patients with Prostate Cancer: A Systematic Review
Grados, D. F. W., Ergun, O., Miller, C. D., Gaburak, P., Frimpong, N., Shittu, O., & Warlick, C. A. (2024) · Cancers · doi:10.3390/cancers16081549 · Cited by 12
Liwinski, T., Auer, M. K., Schröder, J., Pieknik, I., Casar, C., Schwinge, D., Henze, L., Stalla, G. K., Lang, U. E., von Klitzing, A., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03548-z · Cited by 14
Trecarten, S. J., Liss, M. A., Hamilton‐Reeves, J. M., & DiGiovanni, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1448116 · Cited by 13
Synthetic microbial consortia for the treatment of Clostridioides difficile infection in mice model
Liu, J., Zhu, W., Lessing, D. J., & Chu, W. (2023) · Microbial Biotechnology · doi:10.1111/1751-7915.14333 · Cited by 11
Gastrointestinal Dysfunction in Neurological and Neurodegenerative Disorders
Raber, J., & Sharpton, T. J. (2023) · Seminars in Neurology · doi:10.1055/s-0043-1771459 · Cited by 16
Microbiota and environmental health monitoring of mouse colonies by metagenomic shotgun sequencing
Lupini, L., Bassi, C., Guerriero, P., Raspa, M., Scavizzi, F., & Sabbioni, S. (2022) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-022-03469-0 · Cited by 12
Paul, D., & Nedelcu, A. M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1040034 · Cited by 11
Testis–Gut‐Reproduction Axis: The Key to Reproductive Health
Zou, H., Chen, W., Hu, B., Liu, H., & Zhao, J. (2024) · Andrologia · doi:10.1155/2024/5020917 · Cited by 15
Ye, G.-C., Peng, H., Xiang, J.-C., Miao, L.-T., Liu, C., Wang, S., & Xia, Q. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-024-05937-7 · Cited by 16
Therapeutic potential of microbiome modulation in reproductive cancers
Oyovwi, M. O., Ben‐Azu, B., & Babawale, K. H. (2025) · Medical Oncology · doi:10.1007/s12032-025-02708-2 · Cited by 11
Wang, C., Dong, T., Rong, X., Yang, Y., Mou, J., Li, J., Ge, J., Mu, X., & Jiang, J. (2025) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-025-06187-w · Cited by 15
Bacteria−Based Synergistic Therapy in the Backdrop of Synthetic Biology
Bao, Y., Cheng, Y., Liu, W., Luo, W., Zhou, P., & Qian, D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.845346 · Cited by 10
Lineage plasticity in prostate cancer: Looking beyond intrinsic alterations
Ferguson, A. M., & Rubin, M. A. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215901 · Cited by 10
Structure-function of DHEA binding proteins
Clark, B. J., & Klinge, C. M. (2022) · Vitamins and hormones · doi:10.1016/bs.vh.2022.12.002 · Cited by 12
Israel, J. S., Marcelin, L.-M., Thomas, C., Szczyrbová, E., Fuessel, S., Puhr, M., Linxweiler, J., Yalala, S., Zwart, W. T., Baniahmad, A., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03125-5 · Cited by 10
IL-17RA/CTSK axis mediates H. pylori-induced castration-resistant prostate cancer growth
Lin, G.-W., Tian, F., Yu, Q., Weng, X., Yu, N., Zhang, F., Yi, C., Ye, J., & Ye, D. (2024) · Oncogene · doi:10.1038/s41388-024-03169-z · Cited by 10
Yang, H., Chen, J., Li, J., Zhang, Z., Zhao, K., Yin, X., Wang, Z., Zhu, G., Yan, X., Jiang, Z., et al. (2024) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2024.10.014 · Cited by 14
He, D., Zhuang, H., Ma, Y., Xia, B., Chatterjee, A., Fan, X., Qi, S., Qian, W., Zhang, Z., & Liu, J. (2025) · Cancers · doi:10.3390/cancers17091556 · Cited by 10
Xu, Y., Mo, Y., Zhou, W., Qin, M., Li, M., Yin, G., Yu, H., Chen, Y., Du, H., Jin, Y., et al. (2025) · Toxicology · doi:10.1016/j.tox.2025.154220 · Cited by 10
Lei, Z., Wu, H., Yang, Y., Hu, Q. C., Lei, Y., Liu, W., Nie, Y., Yang, L., Zhang, X., Yang, C., et al. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116520 · Cited by 9
Molecular Mechanisms of Castrate-Resistant Prostate Cancer
Kotamarti, S., Armstrong, A. J., Polascik, T. J., & Moul, J. W. (2022) · Urologic Clinics of North America · doi:10.1016/j.ucl.2022.07.005 · Cited by 10
Prostate Cancer, Race, and Health Disparity: What We Know
Roach, M., Coleman, P. W., & Kittles, R. A. (2023) · The Cancer Journal · doi:10.1097/ppo.0000000000000688 · Cited by 9
Hu, S., Tang, C., Wang, L., Feng, F., Li, X., Sun, M., & Yao, L. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1375525 · Cited by 10
Cutting‐Edge Advancements in the Antibiotics‐Gut Microbiota‐Urinary Tumour Axis
Wang, J., Li, D., Wu, R., & Feng, D. (2025) · Cell Proliferation · doi:10.1111/cpr.70023 · Cited by 9
Gut microbial-host-isozymes are new targets for diseases
Zhang, Z., Wang, K., & Jiang, C. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2551-3 · Cited by 8
Diet and the microbiome as mediators of prostate cancer risk, progression, and therapy response
Cruz-Lebrón, A., Faiez, T. S., Hess, M. M., & Sfanos, K. S. (2025) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2024.12.001 · Cited by 10
Jia, R. F., Xiao, C., Zhang, Y., Hu, L.-Y., Jun-jun, Y., Zuo, R., Hu, Y., Xie, Y.-H., Ma, X., Li, Q., et al. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101311 · Cited by 11
The microbiome regulates host metabolic health and diseases through microbial enzymes
Ding, Y., Zhang, Z., Wang, K., & Jiang, C. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-026-01195-8 · Cited by 16
Xie, J., Wang, J., Zhao, F., Qiu, X., Chen, J., Jia, Y., Qin, P., Zhu, Y., Zhang, J., & Wang, B. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/6466149 · Cited by 8
Emerging Proteins in CRPC: Functional Roles and Clinical Implications
Kong, P., Zhang, L., Zhang, Z., Feng, K., Sang, Y., Duan, X., Liu, C., Sun, T., Tao, Z., & Liu, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.873876 · Cited by 9
Fukuokaya, W., Mori, K., Yanagisawa, T., Akazawa, K., Shimomura, T., & Kimura, T. (2023) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-023-00695-x · Cited by 8
Current Trends and Challenges of Microbiome Research in Prostate Cancer
Trecarten, S. J., Fongang, B., & Liss, M. A. (2024) · Current Oncology Reports · doi:10.1007/s11912-024-01520-x · Cited by 9
Wang, Y., Long, Z., Hong, Y., Zhou, X., Yang, G., Tang, C., Qu, G., & Li, Y. (2024) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2024.10.007 · Cited by 10
Fujimoto, S., Hatano, K., Banno, E., Motooka, D., Velasco, M. A. D., Kura, Y., Toyoda, S., Hashimoto, M., Adomi, S., Minami, T., et al. (2024) · Cancer Science · doi:10.1111/cas.16408 · Cited by 9
Yu, Y., Papukashvili, D., Ren, R., Rcheulishvili, N., Feng, S., Bai, W., Zhang, H., Xi, Y., Lu, X., & Xing, N. (2023) · Future Oncology · doi:10.2217/fon-2023-0227 · Cited by 7
Clinical Applications of the Gut Microbiome in Genitourinary Cancers
Nguyen, C. B., & Vaishampayan, U. N. (2024) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_100041 · Cited by 8
Ratajczak, W., Skonieczna‐Żydecka, K., Laszczyńska, M., Sipak‐Szmigiel, O., & Lubkowska, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-00466-9 · Cited by 6
Cui, J., Chen, H., Dong, F., Zheng, Q., Wu, J., Feng, B., Guo, D., Jiang, S., Li, M., & Li, J. (2025) · Discover Oncology · doi:10.1007/s12672-025-03296-3 · Cited by 7
Thomas, R., Kenfield, S. A., Williams, M. M. A., Newton, R. U., Aldous, J. W. F., Mitra, A., & Fazili, Z. (2025) · European Urology Oncology · doi:10.1016/j.euo.2025.10.003 · Cited by 7
Wu, B., Quan, C., He, Y., Matsika, J., Huang, J., Liu, B., & Chen, J. (2024) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2024.2371543 · Cited by 7
Microbiota mechanisms in cancer progression and therapy
Zhang, X., Fam, K. T., Dai, T., & Hang, H. C. (2025) · Cell chemical biology · doi:10.1016/j.chembiol.2025.04.005 · Cited by 9
Wang, X., Pan, L., Wang, F., Long, F., Yang, B. X., & Tang, D. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1229177 · Cited by 8
Song, C., Dong, R., Yijing, Z., Li, X., Dong, D., & Song, X. (2024) · Journal of Water Process Engineering · doi:10.1016/j.jwpe.2023.104734 · Cited by 6
Uzelac, M., Xin, R., & Ongkeko, W. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063291 · Cited by 7
Xiong, X., Xu, H., Wang, S., Liao, X., Yi, X., Jin, K., Lei, H., Bai, S., Qiu, S., & Yang, L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.800823 · Cited by 6
Gut microbiota affects prostate cancer risk through steroid hormone biosynthesisPreprint
Kalinen, S., Kallonen, T., Gunell, M., Ettala, O. O., Jambor, I., Knaapila, J., Syvänen, K. T., Taimen, P., POUTANEN, M. H., Ohlsson, C., et al. (2021) · medRxiv · doi:10.1101/2021.08.19.21262274 · Cited by 6
Delineating the nexus between gut-intratumoral microbiome and osteo-immune system in bone metastases
Kapoor, S., Gupta, M., Sapra, L., Kaur, T., & Srivastava, R. K. (2024) · Bone Reports · doi:10.1016/j.bonr.2024.101809 · Cited by 10
Decoding Microbiome’s Role in Prostate Cancer Progression and Treatment Response
Sakellakis, M., Resta, P., Papagianni, E. D., Procter, K. A., Belouka, I., Gioti, K., Anthouli-Anagnostopoulou, F., Chaniotis, D. I., & Beloukas, A. I. (2025) · Diseases · doi:10.3390/diseases13090294 · Cited by 7
Zheng, Z., Xie, D., Han, Y., Li, G., Wang, S., Zhang, X., Huang, T., Xu, W., & Wu, G. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1699308 · Cited by 5
Chen, Y., Du, H., Zhou, W., Qin, M., Li, M., Jin, Y., Xu, Y., Ma, C., Xia, J., Mo, Y., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2025.2610077 · Cited by 7
Wakamori, C., Velasco, M. A. D., Sakai, K., Kura, Y., Matsushita, M., Fujimoto, S., Hatano, K., Nonomura, N., Fujita, K., Nishio, K., et al. (2024) · The Prostate · doi:10.1002/pros.24776 · Cited by 7
The influence of seminal microbiota on human testicular steroidogenesis: a prospective study
Cannarella, R., Curto, R., Condorelli, R. A., Grillo, A., Aversa, A., Calogero, A. E., & Vignera, S. L. (2025) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-024-03351-y · Cited by 5
Role of Microbiota‐Derived Metabolites in Prostate Cancer Inflammation and Progression
Rathinavelu, P. K., Kumar, A., & Kumar, V. (2025) · Cell Biochemistry and Function · doi:10.1002/cbf.70050 · Cited by 6
NK Cell-Microbiota Interaction Biomarker Strategy: Advancing Prostate Cancer Management
Fanijavadi, S., Hansen, T. F., & Zedan, A. H. (2025) · Biomolecules · doi:10.3390/biom15020273 · Cited by 6
Ohlsson, C., Li, L., Horkeby, K., Lawenius, L., Colldén, H., Sjögren, K., Baldanzi, G., Engström, G., Ärnlöv, J., Orho‐Melander, M., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105978 · Cited by 6
Genome-wide association studies in advanced prostate cancer: KYUCOG-1401-A study
Shiota, M., Tatarano, S., Kamoto, T., Matsuyama, H., Sakai, H., Igawa, T., Kamba, T., Fujimoto, N., Sekine, Y., Kimura, H. M., et al. (2023) · Endocrine Related Cancer · doi:10.1530/erc-23-0044 · Cited by 5
The Role of the Microbiome in Cancer Therapies
Chalif, J., Goldstein, N. E. S., Mehra, Y., Spakowicz, D. J., & Chambers, L. (2025) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2024.12.005 · Cited by 7
Microbial-host-isozyme: unveiling a new era in microbiome–host interaction
Miao, L., Tilg, H., & Zheng, M. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2267185 · Cited by 5
Brandon-Mong, G.-J., Chou, C., Wu, T.-Y., Gicana, R. G., Huang, C.-T., Wu, G.-L., Li, Y.-C., Tu, Y.-L., Chang, Y.-Y., Lai, Y.-L., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.12.628284 · Cited by 4
Prostate Cancer at the Microbial Crossroads: Illuminating a New Frontier in Precision Medicine
Kwon, W., Kim, H., & Song, Y. S. (2025) · The World Journal of Men s Health · doi:10.5534/wjmh.250045 · Cited by 5
Metadata
- Authors
- Pernigoni, N., Zagato, E., Calcinotto, A., Troiani, M., Mestre, R. P., Calì, B., Attanasio, G., Troisi, J., Minini, M., Mosole, S., Revandkar, A., Pasquini, E., Elia, A. R., Bossi, D., Rinaldi, A., Rescigno, P., Flohr, P., Hunt, J., Neeb, A., Buroni, L., Guo, C., Welti, J., Ferrari, M., Grioni, M., Gauthier, J., Gharaibeh, R. Z., Palmisano, A., Lucchini, G. M., D’Antonio, E., Merler, S., Bolis, M., Grassi, F., Esposito, A., Bellone, M., Briganti, A., Rescigno, M., Theurillat, J.-P., Jobin, C., Gillessen, S., de Bono, J., & Alimonti, A.
- Affiliations
- Institute of Oncology Research (CH)
- Ente Ospedaliero Cantonale (CH)
- Theoreo Srl, Montecorvino Pugliano, 84090 Salerno, Italy.
- Candiolo Cancer Institute (IT)
- Royal Marsden NHS Foundation Trust (GB)
- IRCCS Ospedale San Raffaele (IT)
- University of Florida Health (US)
- Vita-Salute San Raffaele University (IT)
- University of Verona (IT)
- Mario Negri Institute for Pharmacological Research (IT)
- Institute for Research in Biomedicine (CH)
- IRCCS Humanitas Research Hospital, 20089 Rozzano, Milan, Italy.
- Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK.
- University of Padua (IT)
- Corresponding author
- Pernigoni, Nicolò
- Zagato, Elena
- Calcinotto, Arianna
- Alimonti, Andrea
- ORCID
- Pernigoni, Nicolò
- Zagato, Elena
- Calcinotto, Arianna
- Mestre, Ricardo Pereira
- Calì, Bianca
- Troisi, Jacopo
- Minini, Mirko
- Mosole, Simone
- Pasquini, Emiliano
- Elia, Angela Rita
- Bossi, Daniela
- Rinaldi, Andrea
- Rescigno, Pasquale
- Flohr, Penny
- Neeb, Antje
- Buroni, Lorenzo
- Guo, Christina
- Welti, Jonathan
- Grioni, Matteo
- Gauthier, Josée
- Gharaibeh, Raad Z.
- Palmisano, Anna
- D’Antonio, Eugenia
- Merler, Sara
- Bolis, Marco
- Grassi, Fabio
- Esposito, Antonio
- Bellone, Matteo
- Briganti, Alberto
- Rescigno, Maria
- Theurillat, Jean-Philippe
- Jobin, Christian
- Gillessen, Silke
- de Bono, Johann
- Alimonti, Andrea
- Venue
- Science
- Published
- 2021-10-08
- Volume
- 374
- Issue
- 6564
- Pages
- 216-224
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W3201967841
- Cited by
- 323
- References
- 55
- Citations by year
- 2026: 55 · 2025: 77 · 2024: 63 · 2023: 55 · 2022: 64 · 2021: 9
- FWCI
- 31.37
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- National Institute for Health and Care Research (NF-SI-0617-10099)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- prostate cancer, gut microbiota, commensal bacteria, androgen production, endocrine therapy resistance, androgen deprivation therapy, castration, dihydrotestosterone, testosterone
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Host Microbial Interactions, Aged, Aged, 80 and over, Androgen Antagonists, Androgens, Animals, Anti-Bacterial Agents, Bacteria, Humans, Male, Mice, Inbred C57BL, Middle Aged, Neoplasms, Experimental, Symbiosis, Mice, SCID, Mice, Inbred NOD, Prevotella, Xenograft Model Antitumor Assays, Cell Line, Tumor, Mice, Prostatic Neoplasms, Castration-Resistant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.